Literature DB >> 23026858

Cerebrospinal fluid biomarkers in neurological diseases in children.

Pashtun Shahim1, Jan-Eric Månsson, Niklas Darin, Henrik Zetterberg, Niklas Mattsson.   

Abstract

Analysis of cerebrospinal fluid (CSF) biomarkers is an integral part of neurology. Basic CSF biomarkers, such as CSF/serum albumin ratio and CSF cell counts, have been used to diagnose inflammatory and infectious CNS disorders in adults and children for decades. During recent years, however, numerous biomarkers for neuronal and astroglial injury, as well as disease-specific protein inclusions, have been developed for neurodegenerative disorders in adults. The overall aim of this paper is to give an updated overview of some of these biomarkers with special focus on their possible relevance to neurological disorders in children and adolescents.
Copyright © 2012 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23026858     DOI: 10.1016/j.ejpn.2012.09.005

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  6 in total

Review 1.  Perinatal biomarkers in prematurity: early identification of neurologic injury.

Authors:  Maria Andrikopoulou; Ahmad Almalki; Azadeh Farzin; Christina N Cordeiro; Michael V Johnston; Irina Burd
Journal:  Int J Dev Neurosci       Date:  2014-04-24       Impact factor: 2.457

2.  Cerebrospinal fluid biomarkers in various pediatric neurologic diseases.

Authors:  Jeongho Lee
Journal:  Clin Exp Pediatr       Date:  2022-01-06

3.  Cerebrospinal fluid biomarker candidates associated with human WNV neuroinvasive disease.

Authors:  Christophe Fraisier; Anna Papa; Samuel Granjeaud; Rogier Hintzen; Byron Martina; Luc Camoin; Lionel Almeras
Journal:  PLoS One       Date:  2014-04-02       Impact factor: 3.240

4.  Lipid profile of cerebrospinal fluid in multiple sclerosis patients: a potential tool for diagnosis.

Authors:  L Nogueras; H Gonzalo; M Jové; J Sol; A Gil-Sanchez; J V Hervás; P Valcheva; C Gonzalez-Mingot; M J Solana; S Peralta; R Pamplona; L Brieva
Journal:  Sci Rep       Date:  2019-08-05       Impact factor: 4.379

5.  Promising candidate cerebrospinal fluid biomarkers of seizure disorder, infection, inflammation, tumor, and traumatic brain injury in pediatric patients.

Authors:  Seh Hyun Kim; Soo Ahn Chae
Journal:  Clin Exp Pediatr       Date:  2021-08-23

6.  Evaluation of putative CSF biomarkers in paediatric spinal muscular atrophy (SMA) patients before and during treatment with nusinersen.

Authors:  Jessika Johannsen; Deike Weiss; Anne Daubmann; Leonie Schmitz; Jonas Denecke
Journal:  J Cell Mol Med       Date:  2021-07-27       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.